Back

The prognostic impact of heart rate in atrial fibrillation

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Anticoagulation in atrial fibrillation Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Christina Ji-Young Lee

Nordsjaellands University Hospital, Copenhagen (Denmark)

20 More presentations in this session

Presentation thumbnail
Prothrombin activation fragment (F1+2) as an index of anticoagulant therapy with factor Xa inhibitor in atrial fibrillation
Doctor E. Ueno (Kahoku, JP)
Abstract
Presentation thumbnail
Is there a difference in treatment persistence across oral anticoagulants? Results of a UK cohort study evaluating oral anticoagulation therapy in an atrial fibrillation population
Ms G. Stynes (Uxbridge, GB)
Abstract Slides
Presentation thumbnail
Is major bleeding risk for oral anticoagulants similar between non-valvular atrial fibrillation patients newly initiated on warfarin and propensity-score matched NOAC initiators? A real world study
Professor G. Lip (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Differences in the characteristics of patients with non-valvular atrial fibrillation who are newly prescribed apixaban, rivaroxaban, dabigatran and VKA in general practice in the UK
Ms G. Stynes (Uxbridge, GB)
Abstract Slides
Presentation thumbnail
The HAS-BLED score for prediction of stroke and systemic embolism: insights from the PREvention oF thromboembolic events, European Registry in Atrial Fibrillation (PREFER in AF)
Doctor M. Rohla (Bern, CH)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Anticoagulation in atrial fibrillation

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources